Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

31Phosphorus magnetic resonance spectroscopy study of tissue specific changes in high energy phosphates before and after sertraline treatment of geriatric depression.

Forester BP, Harper DG, Jensen JE, Ravichandran C, Jordan B, Renshaw PF, Cohen BM.

Int J Geriatr Psychiatry. 2009 Aug;24(8):788-97. doi: 10.1002/gps.2230.

PMID:
19382284
2.

The relationship of MRI subcortical hyperintensities to treatment response in a trial of sertraline in geriatric depressed outpatients.

Salloway S, Boyle PA, Correia S, Malloy PF, Cahn-Weiner DA, Schneider L, Krishnan KR, Nakra R.

Am J Geriatr Psychiatry. 2002 Jan-Feb;10(1):107-11.

PMID:
11790641
3.
4.

Depression and panic disorder after heart transplantation--treatment with sertraline.

Hesslinger B, Van de Loo A, Klecha D, Härter M, Schmidt-Schweda S.

Pharmacopsychiatry. 2002 Jan;35(1):31-2.

PMID:
11819158
5.

An open-label preliminary trial of sertraline for treatment of major depression after acute myocardial infarction (the SADHAT Trial). Sertraline Anti-Depressant Heart Attack Trial.

Shapiro PA, Lespérance F, Frasure-Smith N, O'Connor CM, Baker B, Jiang JW, Dorian P, Harrison W, Glassman AH.

Am Heart J. 1999 Jun;137(6):1100-6.

PMID:
10347338
6.

[Efficacy and acceptability of tianeptine and sertraline in the acute treatment phase of depression].

Szádóczky E, Füredi J.

Encephale. 2002 Jul-Aug;28(4):343-9. French.

PMID:
12232543
7.

An open study of sertraline in patients with major depression who failed to respond to moclobemide.

George T, Theodoros MT, Chiu E, Krapivensky N, Hokin A, Tiller JW.

Aust N Z J Psychiatry. 1999 Dec;33(6):889-95.

PMID:
10619217
8.

Efficacy of the novel antidepressant agomelatine on the circadian rest-activity cycle and depressive and anxiety symptoms in patients with major depressive disorder: a randomized, double-blind comparison with sertraline.

Kasper S, Hajak G, Wulff K, Hoogendijk WJ, Montejo AL, Smeraldi E, Rybakowski JK, Quera-Salva MA, Wirz-Justice AM, Picarel-Blanchot F, Baylé FJ.

J Clin Psychiatry. 2010 Feb;71(2):109-20. doi: 10.4088/JCP.09m05347blu.

PMID:
20193645
10.

The influence of 4-week treatment with sertraline on the combined T3/TRH test in depressed patients.

Schüle C, Baghai TC, Alajbegovic L, Schwarz M, Zwanzger P, Eser D, Schaaf L, Möller HJ, Rupprecht R.

Eur Arch Psychiatry Clin Neurosci. 2005 Oct;255(5):334-40. Epub 2005 Mar 5.

PMID:
15747035
12.

Acute efficacy of fluoxetine versus sertraline and paroxetine in major depressive disorder including effects of baseline insomnia.

Fava M, Hoog SL, Judge RA, Kopp JB, Nilsson ME, Gonzales JS.

J Clin Psychopharmacol. 2002 Apr;22(2):137-47.

PMID:
11910258
13.

Sertraline and cognitive behavioral therapy for depressed alcoholics: results of a placebo-controlled trial.

Moak DH, Anton RF, Latham PK, Voronin KE, Waid RL, Durazo-Arvizu R.

J Clin Psychopharmacol. 2003 Dec;23(6):553-62.

PMID:
14624185
14.

Comparative efficacy of sertraline vs. fluoxetine in patients age 70 or over with major depression.

Finkel SI, Richter EM, Clary CM, Batzar E.

Am J Geriatr Psychiatry. 1999 Summer;7(3):221-7.

PMID:
10438693
15.

Age-related changes in brain energetics and phospholipid metabolism.

Forester BP, Berlow YA, Harper DG, Jensen JE, Lange N, Froimowitz MP, Ravichandran C, Iosifescu DV, Lukas SE, Renshaw PF, Cohen BM.

NMR Biomed. 2010 Apr;23(3):242-50. doi: 10.1002/nbm.1444.

PMID:
19908224
16.

Multinuclear magnetic resonance spectroscopy of high-energy phosphate metabolites in human brain following oral supplementation of creatine-monohydrate.

Lyoo IK, Kong SW, Sung SM, Hirashima F, Parow A, Hennen J, Cohen BM, Renshaw PF.

Psychiatry Res. 2003 Jun 30;123(2):87-100.

PMID:
12850248
17.

Predictors of response to sertraline in patients with major depression.

Morishita S, Kinoshita T.

Hum Psychopharmacol. 2008 Dec;23(8):647-51. doi: 10.1002/hup.969.

PMID:
18821727
18.

Early improvement is a predictor of treatment outcome in patients with mild major, minor or subsyndromal depression.

Tadić A, Helmreich I, Mergl R, Hautzinger M, Kohnen R, Henkel V, Hegerl U.

J Affect Disord. 2010 Jan;120(1-3):86-93. doi: 10.1016/j.jad.2009.04.014. Epub .

PMID:
19428118
19.

Addition of risperidone to sertraline improves sertraline-resistant refractory depression without influencing plasma concentrations of sertraline and desmethylsertraline.

Yoshimura R, Umene-Nakano W, Ueda N, Ikenouchi-Sugita A, Hori H, Nakamura J.

Hum Psychopharmacol. 2008 Dec;23(8):707-13. doi: 10.1002/hup.979.

PMID:
18803170
20.

Psychomotor changes in major depressive disorder during sertraline treatment.

Schrijvers D, Maas YJ, Pier MP, Madani Y, Hulstijn W, Sabbe BG.

Neuropsychobiology. 2009;59(1):34-42. doi: 10.1159/000205516. Epub 2009 Mar 6.

PMID:
19270462
Items per page

Supplemental Content

Write to the Help Desk